- Home
- LEDS vs APRE Comparison
LEDS vs APRE Comparison
Compare LEDS & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- APRE
- Stock Information
- Founded
- LEDS 2005
- APRE 2006
- Country
- LEDS Taiwan
- APRE United States
- Employees
- LEDS N/A
- APRE 8
- Industry
- LEDS Semiconductors
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LEDS Technology
- APRE Health Care
- Exchange
- LEDS Nasdaq
- APRE Nasdaq
- Market Cap
- LEDS 13.8M
- APRE 8.4M
- IPO Year
- LEDS 2010
- APRE 2019
- Fundamental
- Price
- LEDS $2.45
- APRE $1.55
- Analyst Decision
- LEDS
- APRE Strong Buy
- Analyst Count
- LEDS 0
- APRE 2
- Target Price
- LEDS N/A
- APRE $15.50
- AVG Volume (30 Days)
- LEDS 34.8K
- APRE 29.2K
- Earning Date
- LEDS 04-10-2025
- APRE 05-13-2025
- Dividend Yield
- LEDS N/A
- APRE N/A
- EPS Growth
- LEDS N/A
- APRE N/A
- EPS
- LEDS N/A
- APRE N/A
- Revenue
- LEDS $14,780,000.00
- APRE $1,502,581.00
- Revenue This Year
- LEDS N/A
- APRE N/A
- Revenue Next Year
- LEDS N/A
- APRE N/A
- P/E Ratio
- LEDS N/A
- APRE N/A
- Revenue Growth
- LEDS 160.76
- APRE 157.63
- 52 Week Low
- LEDS $0.92
- APRE $1.41
- 52 Week High
- LEDS $2.94
- APRE $5.90
- Technical
- Relative Strength Index (RSI)
- LEDS 60.10
- APRE 31.36
- Support Level
- LEDS $1.80
- APRE $1.41
- Resistance Level
- LEDS $2.31
- APRE $1.59
- Average True Range (ATR)
- LEDS 0.20
- APRE 0.10
- MACD
- LEDS 0.00
- APRE 0.03
- Stochastic Oscillator
- LEDS 74.67
- APRE 31.26
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.